sorbitol and cardiovascular agents

sorbitol has been researched along with cardiovascular agents in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (71.43)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
SCHEMBRA, FW	1
HAGEN, H	1
CAUSEMANN, H; WICH, S	1
DUCLOUX, G; WAREMBOURG, H	1
JOUGLEUX, M	1
Kolodgie, FD; Ladich, E; Naisbitt, S; Nakano, M; Otsuka, F; Pacheco, E; Rousselle, S; Virmani, R; Yazdani, SK	1
Bosiers, M; Duda, S; Krankenberg, H; Naisbitt, S; Ricke, J; Rosenfield, K; Scheinert, D; Tepe, G; Zeller, T	1

Trials

1 trial(s) available for sorbitol and cardiovascular agents

Article	Year
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Carriers; Equipment Design; Europe; Female; Femoral Artery; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Polysorbates; Popliteal Artery; Radiography; Secondary Prevention; Sorbitol; Time Factors; Treatment Outcome; Vascular Access Devices	2014

Article

Year

The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.

JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:1

Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Carriers; Equipment Design; Europe; Female; Femoral Artery; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Polysorbates; Popliteal Artery; Radiography; Secondary Prevention; Sorbitol; Time Factors; Treatment Outcome; Vascular Access Devices

2014

Other Studies

6 other study(ies) available for sorbitol and cardiovascular agents

Article	Year
[Sorbosan in gallbladder and liver diseases]. Die Medizinische Welt, 1961, Feb-25, Volume: 8 Topics: Cardiovascular Agents; Cholecystitis; Humans; Liver Diseases; Muscle Relaxants, Central; Sorbitol	1961
[On the technic of gallbladder reflex examination]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1961, Volume: 95 Topics: Cardiovascular Agents; Cholecystography; Gallbladder; Humans; Muscle Relaxants, Central; Reflex, Abnormal; Sorbitol	1961
[Report on experiences with Sorbosan]. Die Medizinische Welt, 1962, Mar-17, Volume: 11 Topics: Biliary Tract; Biliary Tract Diseases; Cardiovascular Agents; Muscle Relaxants, Central; Sorbitol	1962
[ON THE USE OF THE SORBITOL-HEXADIPHANE COMBINATION IN DIGESTIVE PATHOLOGY]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1963, Volume: 8 Topics: Cardiovascular Agents; Digestion; Gastroenterology; Muscle Relaxants, Central; Sorbitol	1963
[NEW THERAPY OF CONSTIPATION IN CHILDREN]. Gazette medicale de France, 1964, Nov-25, Volume: 71 Topics: Adolescent; Cardiovascular Agents; Constipation; Geriatrics; Infant; Muscle Relaxants, Central; Sorbitol	1964
Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Jan-01, Volume: 83, Issue:1 Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Equipment Design; Femoral Artery; Models, Animal; Paclitaxel; Polysorbates; Punctures; Sorbitol; Sus scrofa; Vascular Access Devices; Wound Healing	2014